NLRP3 and benign neoplasm: The NLRP3 inflammasome is activated in the ischemic heart and the inhibition of the NLRP3-initiated inflammasome during experimental myocardial infarction minimizes the activation of caspase-1 in the heart and improves LV remodeling and function [14, 47–50].